Abstract: The present invention relates to an organic resin, in particular acrylic, vinyl or acrylic-vinyl, of low molecular weight and functionalized with carboxyl and carbonyl groups, and also to an aqueous dispersion comprising said organic resin and a crosslinking agent, for the preparation of a one-component crosslinkable coating composition with a high level of performance.

Abstract: The invention relates to an aqueous polymer dispersion, with said polymer comprising, in its structure, monomer units incorporated from a composition of monomers comprising: a) at least one (meth)acrylic monomer which is a C1-C18 (meth)acrylic ester, without any ionic group, b) at least one ethylenically unsaturated monomer carrying at least one carboxylic acid group, c) at least one ethylenically unsaturated monomer carrying a tertiary amine, and with said polymer additionally carrying grafted blocked silane groups in the —Si(OR1)3 or —Si—R2(OR1)2 or —Si—(R2)2(OR1), with R1, R2 being an identical or different C1 to C4 alkyl, and with said grafted blocked silane groups being incorporated by at least one or two routes or their combination. The invention also relates to a coating composition comprising said dispersion of the invention and to its use for aqueous protective coating compositions for wood.

Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.

Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.

Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.

Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.

Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.

Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):

Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):

Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):

Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): wherein the symbols are defined in the specification.